“…The reasons for this are (i) the emergence of novel pathogens as currently experienced with SARS-CoV-2 [ 5 ], (ii) the selection and global spread of multidrug-resistant organisms (MDROs) [ 6 , 7 , 8 , 9 , 10 ], (iii) the medical progress characterized by the increased application of immune system-impairing procedures and colonization-vulnerable devices [ 11 , 12 , 13 , 14 , 15 , 16 ], (iv) the demographic changes leading to higher susceptibility of subpopulations to infectious diseases, such as the increase of older and multi-morbid individuals [ 17 , 18 , 19 ] and (v) the migration and lifestyle aspects leading to the transmission and distribution of MDROs [ 20 , 21 , 22 ]. Emerging clonal lineages of notorious MDROs with changed epidemiology and host spectra (e.g., community- and livestock-associated MRSA and hypervirulent, multi-resistant Klebsiella pneumoniae lineages) also add to the burden of diseases, necessitating health behavior programs [ 6 , 9 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ].…”